Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-LO pathway. It plays a significant role in promoting various leukocyte functions, such as aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. LTB4 exhibits chemotactic and chemokinetic effects on human polymorphonuclear leukocytes at subnanomolar concentrations (3.9 x 10^-10 M), while at higher concentrations (1.0 x 10^-7 M), it leads to neutrophil aggregation, degranulation, and superoxide anion production. LTB4 MaxSpec standard is a quantitative grade standard specifically prepared for mass spectrometry and related applications, ensuring identity, purity, stability, and concentration specifications.

71160-24-2

Post Buying Request

71160-24-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71160-24-2 Usage

Uses

Used in Inflammation and Immunology Research:
LEUKOTRIENE B4 is used as a potent chemokine for studying its roles in inflammation and immunology. It aids in understanding the complex processes involved in these fields and contributes to the development of targeted therapies for various inflammatory and immune-related disorders.
Used in Nervous System Research:
LEUKOTRIENE B4 is used as a signaling molecule in the nervous system, helping researchers explore its potential involvement in neurological processes and disorders. This knowledge can contribute to the advancement of treatments for neurological conditions.
Used in Brain Research:
LEUKOTRIENE B4 is used as a bioactive molecule in brain research, where it is studied for its potential impact on brain function and the development of neurological diseases. Understanding its role in the brain can lead to the discovery of new therapeutic approaches for brain-related disorders.
Used in Skin Research:
LEUKOTRIENE B4 is used as a key player in skin research, where its role in skin inflammation, immune responses, and other skin-related processes is investigated. This research can contribute to the development of novel treatments for skin conditions and diseases.

Biological Activity

Potent lipid inflammatory mediator derived from the 5-lipoxygenase pathway of arachidonic acid metabolism. Binds to BLT 1 and BLT 2 receptors and acts as a potent chemotactic agent and activator of leukocytes. Also displays antiviral activity towards DNA viruses and retroviruses.

Biochem/physiol Actions

Proinflammatory agent. Stimulates c-Fos and c-Jun proto-oncogene transcription in human monocytes. Stimulates chemotaxis, aggregation, and degranulation of polymorphonuclear leukocytes.

Check Digit Verification of cas no

The CAS Registry Mumber 71160-24-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,1,6 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 71160-24:
(7*7)+(6*1)+(5*1)+(4*6)+(3*0)+(2*2)+(1*4)=92
92 % 10 = 2
So 71160-24-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7-,9-6-,14-10+,15-11+/t18-,19-/m1/s1

71160-24-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (L0517)  Leukotriene B4  ~100 μg/mL in ethanol, ≥97%

  • 71160-24-2

  • L0517-10UG

  • 2,788.11CNY

  • Detail
  • Sigma

  • (L0517)  Leukotriene B4  ~100 μg/mL in ethanol, ≥97%

  • 71160-24-2

  • L0517-25UG

  • 4,400.37CNY

  • Detail
  • Sigma

  • (L0517)  Leukotriene B4  ~100 μg/mL in ethanol, ≥97%

  • 71160-24-2

  • L0517-50UG

  • 7,605.00CNY

  • Detail

71160-24-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name leukotriene B4

1.2 Other means of identification

Product number -
Other names Leukotriene B4 Lipid Maps MS Standard

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71160-24-2 SDS

71160-24-2Relevant articles and documents

Catalytic asymmetric synthesis of Leukotriene B4

Yang, Pengfei,Zhong, Jiangchun,Ji, Kaijie,Yin, Jingwei,Li, Shuoning,Wei, Siyuan,Zhou, Yun,Wang, Lifeng,Wang, Min,Bian, Qinghua

, p. 1596 - 1601 (2017/10/20)

Leukotriene B4 1 was prepared from two chiral synthons 8 and 14. The chiral secondary alcohols of 8 and 14 were constructed by BINOL/Ti(OiPr)4 catalyzed enantioselective alkynylzinc addition to aldehydes.

An efficient total synthesis of leukotriene B4

Primdahl, Karoline Gangestad,Tungen, Jorn Eivind,Aursnes, Marius,Hansen, Trond Vidar,Vik, Anders

, p. 5412 - 5417 (2015/05/20)

Lipid mediators have attracted great interest from scientists within the chemical, medicinal, and pharmaceutical research community. One such example is leukotriene B4 which has been the subject of many pharmacological studies. Herein, we report a convergent and stereoselective synthesis of this potent lipid mediator in 5% yield over 10 steps in the longest linear sequence from commercial starting materials. The key steps were a stereocontrolled acetate-aldol reaction with Nagao's chiral auxiliary and a Z-selective Boland reduction. All spectroscopic data were in agreement with those previously reported.

COX-2-dependent and -independent biosynthesis of dihydroxy-arachidonic acids in activated human leukocytes

Tejera, Noemi,Boeglin, William E.,Suzuki, Takashi,Schneider, Claus

scheme or table, p. 87 - 94 (2012/03/26)

Biosynthesis of 5,15-dihydroxyeicosatetraenoic acid (5,15-diHETE) in leukocytes involves consecutive oxygenation of arachidonic acid by 5-lipoxygenase (LOX) and 15-LOX in either order. Here, we analyzed the contribution of cyclooxygenase (COX)-2 to the biosynthesis of 5,15-di-HETE and 5,11-diHETE in isolated human leukocytes activated with lipopolysaccharide and calcium ionophore A23187. Transformation of arachidonic acid was initiated by 5-LOX providing 5 S -HETE as a substrate for COX-2 forming 5 S,15 S -diHETE, 5 S,15 R -diHETE, and 5 S,11 R -di-HETE as shown by LC/MS and chiral phase HPLC analyses. The levels of 5,15-diHETE were 0.45 ± 0.2 ng/106 cells (mean ± SEM, n = 6), reaching about half the level of LTB 4 (1.3 ± 0.5 ng/106 cells, n = 6). The COX-2 specific inhibitor NS-398 reduced the levels of 5,15-diHETE to below 0.02 ng/106 cells in four of six samples. Similar reduction was achieved by MK-886, an inhibitor of 5-LOX activating protein but the above differences were not statistically significant. Aspirin treatment of the activated cells allowed formation of 5,15-diHETE (0.1 ± 0.05 ng/106 cells, n = 6) but, as expected, abolished formation of 5,11-diHETE. The mixture of activated cells also produced 5 S,12 S -diHETE with the unusual 6 E,8 Z,10 E double bond configuration, implicating biosynthesis by 5-LOX and 12-LOX activity rather than by hydrolysis of the leukotriene A 4 -epoxide. Exogenous octadeuterated 5 S -HETE and 15 S -HETE were converted to 5,15-diHETE, implicating that multiple oxygenation pathways of arachidonic acid occur in activated leukocytes. The contribution of COX-2 to the biosynthesis of dihydroxylated derivatives of arachidonic acid provides evidence for functional coupling with 5-LOX in activated human leukocytes. Copyright

Preparation of high specific activity tritium-labelled leukotriene B 4 suitable for radioligand binding assay

Schramm, Stanislav I.,Nagaev, Igor Yu.,Sabirsh, Alan,Shevchenko, Valeriy P.,Arkhipova, Anastasiya S.,Haeggstroem, Jesper Z.,Myasoedov, Nikolay F.

, p. 101 - 105 (2008/09/20)

We describe a method of preparation of high specific activity tritium-labelled leukotriene (LT) B4 from [5,6,8,9,11,12, 14,15- 3H] arachidonic acid (AA; 6.66 TBq/mmol) utilizing a LTB 4-synthesizing enzyme system from rat basophilic leukemia (RBL-1) cells. It was shown that both cyclooxygenase inhibitor indomethacin and adenosine 5′-triphosphate induced [3H] AA transformation to [3H] LTB4. In optimized conditions up to 15% of total radioactivity of the incubation mixture was present in [3H] LTB 4. A separation of [3H] LTB4 from other labelled C20:4 products was achieved by a three-step reverse phase-high-performance liquid chromatography in methanol- and acetonitrile-based solvent systems. [3H] LTB4 was confirmed to be identical to the naturally occurring LTB4 by a radioligand binding assay using a culture of HF1 cells that express a BLT1 receptor. Copyright

An atom-economic and selective ruthenium-catalyzed redox isomerization of propargylic alcohols. An efficient strategy for the synthesis of leukotrienes

Trost, Barry M.,Livingston, Robert C.

supporting information; experimental part, p. 11970 - 11978 (2009/02/05)

Catalytic ruthenium complexes in conjunction with an indium cocatalyst and Broensted acid isomerize primary and secondary propargylic alcohols in good yields to provide trans enals and enones exclusively. Readily available indenylbis(triphenylphosphine)ruthenium chloride, in the presence of indium triflate and camphorsulfonic acid, gives the best turnover numbers and reactivity with the broadest range of substrates. Deuterium labeling experiments suggest that the process occurs through propargylic hydride migration followed by protic cleavage of the resultant vinylruthenium intermediate. Application of this method to the synthesis of leukotriene B4 demonstrates its utility and extraordinary selectivity.

Total synthesis of 12(R)-HETE, 12(S)-HETE, 2H2-12(R)-HETE and LTB4 from racemic glycidol via hydrolytic kinetic resolution

Rodríguez,Nomen,Spur,Godfroid,Lee

, p. 25 - 37 (2007/10/03)

The total synthesis of 12(R)-HETE, 12(S)-HETE (Samuelsson's HETE), [14,15-2H2]-12(R)-HETE and Leukotriene B4 from racemic glycidol is described. The key steps are the hydrolytic kinetic resolution of racemic TES-glycidol with salen-Co catalyst and the selective oxidation of primary silyl ethers, in the presence of secondary ones, under Swern conditions to give a short entry to both enantiomers of 12-HETE and LTB4.

Application of the low-valent titanium reductive elimination of 1,6-dibenzoate-2,4-dienes to the total synthesis of 6(E)-5(S)-12(R)-leukotriene B4

Solladie, Guy,Stone, Guy B.,Hamdouchi, Chafiq

, p. 1807 - 1810 (2007/10/02)

A stereoselective synthesis of 6(E)-5(S)-12(R)-leukotriene B4 is described in this paper, using a novel reaction, the low-valent titanium induced reductive elimination of a 1,6-dibenzoate-2,4-diene, for the selective synthesis of the trans-trie

Application of Sodium Amalgam Reductive Elimination of Allylic Dibenzoates to the Total Synthesis of 5(S)-12(R) Leukotriene B4

Solladie, Guy,Urbano, Antonio,Stone, Guy B.

, p. 6489 - 6492 (2007/10/02)

A stereoselective synthesis of 5(S)-12(R) LTB4 is described in this paper using a novel reaction, the sodium amalgam induced reductive elimination of allylic dibenzoates for the selective synthesis of the E,E,Z-triene moiety.The creation of the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71160-24-2